IL87778A0 - Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation - Google Patents

Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation

Info

Publication number
IL87778A0
IL87778A0 IL87778A IL8777888A IL87778A0 IL 87778 A0 IL87778 A0 IL 87778A0 IL 87778 A IL87778 A IL 87778A IL 8777888 A IL8777888 A IL 8777888A IL 87778 A0 IL87778 A0 IL 87778A0
Authority
IL
Israel
Prior art keywords
therapeutically active
preparation
pharmaceutical compositions
active proteins
compositions containing
Prior art date
Application number
IL87778A
Other versions
IL87778A (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL87778A0 publication Critical patent/IL87778A0/en
Publication of IL87778A publication Critical patent/IL87778A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The pharmaceutical preparations are for topical use, contain one or more stabilised therapeutically active proteins and, where appropriate, customary auxiliaries, vehicles and additives, and are prepared as described using physiologically tolerated hydrophobic substances for stabilising proteins.
IL87778A 1987-09-17 1988-09-16 Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation IL87778A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873731255 DE3731255A1 (en) 1987-09-17 1987-09-17 Stabilization of therapeutically active proteins in pharmaceutical preparations

Publications (2)

Publication Number Publication Date
IL87778A0 true IL87778A0 (en) 1989-03-31
IL87778A IL87778A (en) 1993-05-13

Family

ID=6336244

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87778A IL87778A (en) 1987-09-17 1988-09-16 Topical pharmaceutical compositions in the form of a hydrogel containing stabilized therapeutically active proteins and their preparation

Country Status (20)

Country Link
EP (1) EP0307857B1 (en)
JP (1) JP2783552B2 (en)
KR (1) KR970008112B1 (en)
AT (1) ATE126063T1 (en)
AU (1) AU615473B2 (en)
CA (1) CA1329121C (en)
DD (1) DD274562A5 (en)
DE (2) DE3731255A1 (en)
DK (1) DK516288A (en)
ES (1) ES2077559T3 (en)
FI (1) FI95770C (en)
GR (1) GR3017432T3 (en)
HU (1) HU203045B (en)
IE (1) IE70908B1 (en)
IL (1) IL87778A (en)
NO (1) NO179436C (en)
NZ (1) NZ226209A (en)
PT (1) PT88539B (en)
RU (1) RU2093145C1 (en)
ZA (1) ZA886903B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
JPH0776527A (en) * 1993-06-28 1995-03-20 Hayashibara Biochem Lab Inc Semi-solid preparation and production thereof
ITMI20031640A1 (en) * 2003-08-08 2005-02-09 Mipharm S P A BASE FOR BIOADHESIVE GEL.
CU23432B6 (en) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS
US9555120B2 (en) * 2010-05-04 2017-01-31 Viscogel Ab Chitosan composition
CA3066722A1 (en) * 2017-06-12 2018-12-20 Lakewood Amedex, Inc Bisphosphocin gel formulations and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5413223A (en) * 1977-07-01 1979-01-31 Ricoh Co Ltd Printer unit
GB2016015B (en) * 1978-01-22 1982-05-06 Hayashibara Co Method of preparing interferon and preparations containing interferon
JPS5598118A (en) * 1979-01-18 1980-07-25 Hayashibara Takeshi Preparation of type-2 interferon and drug containing the same
FR2513124B1 (en) * 1981-07-21 1989-11-17 Hayashibara Biochem Lab PRODUCTION AND APPLICATIONS OF THE TARGET CELL LYSE FACTOR
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
JPS5892622A (en) * 1981-11-28 1983-06-02 Sunstar Inc Pharmaceutical preparation containing stably compounded interferon
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
JPS5910524A (en) * 1982-07-08 1984-01-20 Toray Ind Inc Interferon composition and its preparation
JPS6061535A (en) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト Pharmaceutical composition
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
DE3603444A1 (en) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K PHARMACEUTICAL PREPARATIONS FOR STABILIZING INTERFERON ALPHA
US4822605A (en) * 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like

Also Published As

Publication number Publication date
HU203045B (en) 1991-05-28
ATE126063T1 (en) 1995-08-15
NO884123L (en) 1989-03-20
EP0307857B1 (en) 1995-08-09
AU2231688A (en) 1989-03-23
NO179436B (en) 1996-07-01
NZ226209A (en) 1991-06-25
PT88539B (en) 1992-11-30
NO179436C (en) 1996-10-09
ES2077559T3 (en) 1995-12-01
IE70908B1 (en) 1997-01-15
ZA886903B (en) 1990-05-30
DK516288A (en) 1989-03-18
DE3731255A1 (en) 1989-04-06
RU2093145C1 (en) 1997-10-20
AU615473B2 (en) 1991-10-03
JP2783552B2 (en) 1998-08-06
GR3017432T3 (en) 1995-12-31
JPH01102029A (en) 1989-04-19
DK516288D0 (en) 1988-09-16
IE882812L (en) 1989-03-17
KR970008112B1 (en) 1997-05-21
PT88539A (en) 1988-10-01
FI884240A (en) 1989-03-18
EP0307857A1 (en) 1989-03-22
FI884240A0 (en) 1988-09-15
KR890004719A (en) 1989-05-09
CA1329121C (en) 1994-05-03
IL87778A (en) 1993-05-13
FI95770B (en) 1995-12-15
DD274562A5 (en) 1989-12-27
NO884123D0 (en) 1988-09-16
FI95770C (en) 1996-03-25
HUT47436A (en) 1989-03-28
DE3854290D1 (en) 1995-09-14

Similar Documents

Publication Publication Date Title
IE892646L (en) Pharmaceutical combination preparations for use in¹anti-neoplastic therapy
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
ZA885192B (en) Pharmaceutical preparations
PT97160A (en) Process for the preparation of stable compositions for parenteral administration containing a biologically active protein, polypeptide or polypeptide
DK653688A (en) STABILIZED PHARMACEUTICAL ACTIVE COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND STABLE PHARMACEUTICAL PREPARATIONS
ATE148630T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING STABILIZED DERIVATIVES OF VITAMIN D2 AND D3
AU557980B2 (en) Perfluorohydrocarbons as vehicles for drugs
EP0370481A3 (en) Pharmaceutical preparations for the enhanced resorption of antibacterial compounds
IL87778A0 (en) Pharmaceutical compositions containing stabilized therapeutically active proteins and their preparation
TW290455B (en)
PT996462E (en) PREPARATIONS OF PHARMACEUTICAL COMBINATIONS CONTAINING ERYTHROPOIETIN AND MODIFIED HEMOGLOBINS
AU563762B2 (en) S-adenosyl-l-methionine salts preparation
AU1518492A (en) Pharmaceutical compositions for transcutaneous administration
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
SG153894G (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
IT1273460B (en) Pharmaceutical formulations having antiviral action for topical use
GR3032639T3 (en) Vehicles for oral adminstration of pharmaceutically active acide labile substances.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXTN Extension order renewed